Trial reportAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists2013
Underutilization of cardiovascular medications: effect of a continuity-of-care program.
Trial report in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00513903 (Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases), which is not on this map. Cited by 10 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Who cites it
10 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Discharge planning from hospital.The Cochrane database of systematic reviews · 2022Pooled it
- Improving Treatment Adherence in Heart Failure.Deutsches Arzteblatt international · 2016Pooled it
- Discharge planning from hospital.The Cochrane database of systematic reviews · 2016Pooled it
- Effect of a care transition intervention by pharmacists: an RCT.BMC health services research · 2014Trial
- Implementation: The Final Step in Translating Innovation.Structural heart : the journal of the Heart Team · 2024Article
- Pharmacist-Led Follow-Up Program for Rural Patients with Acute Coronary Syndrome: The PLURAL-ACS Pilot Program.The Canadian journal of hospital pharmacy · 2024Article
- Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-experimental study.International journal of clinical pharmacy · 2023Article
- Multidimensional Interventions on Supporting Disease Management for Hospitalized Patients with Heart Failure: The Role of Clinical and Community Pharmacists.Journal of clinical medicine · 2023Review
- Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.Journal of the American Heart Association · 2016Review
- Current use and costs of electronic health records for clinical trial research: a descriptive study.CMAJ openArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThe effect of hospital pharmacists' enhanced communication with patients and community providers on the underutilization of key cardiovascular medications was studied.
methodsPatients enrolled in the Iowa Continuity of Care study were eligible for inclusion in this study if they had a diagnosis of hypertension, hyperlipidemia, heart failure, coronary artery disease, or a combination of these diagnoses. Eligible patients also had to be admitted to the internal medicine, family medicine, cardiology, or orthopedics services and receive their usual medical care in the community and their prescriptions from a community pharmacy. Patients were randomized to receive minimal intervention, enhanced intervention, or usual care. For the minimal- and enhanced-intervention groups, pharmacy case managers (PCMs) performed comprehensive medication reconciliations and identified drug-related problems within 24 hours of admission. The PCMs made recommendations to the inpatient care team and to patients' community physicians. For patients in the enhanced-intervention group, the PCM developed a discharge care plan containing the patient's discharge medication list. PCMs made specific recommendations to optimize regimens that did not meet current guidelines or medications that were underutilized. Medication underutilization was assessed at admission, discharge, 30 days after discharge, and 90 days after discharge.
resultsA total of 732 patients were enrolled in this study. There were no significant differences among the three study groups. Overall, the rate of underutilization remained constant among all three groups, despite enhanced pharmacist involvement in both intervention groups.
conclusionEnhanced interventions by PCMs had no effect on the underutilization of key cardiovascular drugs during hospitalization or after hospital discharge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.